SLGL (Sol-Gel Technologies) Beneish M-Score: -3.56 (As of Jun. 26, 2026)


SLGL Sol-Gel Technologies Ltd SLGL
56 GF Score
Price $73.50
GF Value $65.37
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Beneish M-Score?

Sol-Gel Technologies SLGL +1.87% 56 Beneish M-Score is -3.56 as of Jun. 26, 2026. GuruFocus rates SLGL with a GF Score™ of 56/100 and a GF Value™ of $65.37 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 831 Biotechnology companies, Sol-Gel Technologies ranks better than 84.12% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.56 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Sol-Gel Technologies's Beneish M-Score or its related term are showing as below:

SLGL' s Beneish M-Score Range Over the Past 10 Years
Min: -5.97   Med: -3.11   Max: 154.86
Current: -3.56

During the past 11 years, the highest Beneish M-Score of Sol-Gel Technologies was 154.86. The lowest was -5.97. And the median was -3.11.


Sol-Gel Technologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies Beneish M-Score Chart

Sol-Gel Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 -1.37 -5.20 4.35 -3.56

Sol-Gel Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.56 0.00

SLGL vs ALEC, LENZ, CNXU: Beneish M-Score Comparison

For the Biotechnology subindustry, Sol-Gel Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sol-Gel Technologies Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's Beneish M-Score falls into.


SLGL
56GF Score
Sol-Gel Technologies Ltd SLGL
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sol-Gel Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sol-Gel Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.3258+0.528 * 1+0.404 * 0.7292+0.892 * 1.6804+0.115 * 1.4657
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.4323+4.679 * -0.215563-0.327 * 1.2962
=-3.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $1.97 Mil.
Revenue was $19.39 Mil.
Gross Profit was $19.39 Mil.
Total Current Assets was $26.97 Mil.
Total Assets was $29.92 Mil.
Property, Plant and Equipment(Net PPE) was $1.17 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.11 Mil.
Selling, General, & Admin. Expense(SGA) was $4.18 Mil.
Total Current Liabilities was $6.17 Mil.
Long-Term Debt & Capital Lease Obligation was $0.50 Mil.
Net Income was $-6.13 Mil.
Gross Profit was $0.00 Mil.
Cash Flow from Operations was $0.32 Mil.
Total Receivables was $3.60 Mil.
Revenue was $11.54 Mil.
Gross Profit was $11.54 Mil.
Total Current Assets was $31.30 Mil.
Total Assets was $35.85 Mil.
Property, Plant and Equipment(Net PPE) was $1.63 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.23 Mil.
Selling, General, & Admin. Expense(SGA) was $5.75 Mil.
Total Current Liabilities was $5.29 Mil.
Long-Term Debt & Capital Lease Obligation was $0.88 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.968 / 19.388) / (3.595 / 11.538)
=0.101506 / 0.311579
=0.3258

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.538 / 11.538) / (19.388 / 19.388)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (26.971 + 1.167) / 29.917) / (1 - (31.295 + 1.628) / 35.846)
=0.059465 / 0.081543
=0.7292

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=19.388 / 11.538
=1.6804

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.233 / (0.233 + 1.628)) / (0.109 / (0.109 + 1.167))
=0.125202 / 0.085423
=1.4657

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4.176 / 19.388) / (5.749 / 11.538)
=0.215391 / 0.498267
=0.4323

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.496 + 6.171) / 29.917) / ((0.878 + 5.285) / 35.846)
=0.22285 / 0.17193
=1.2962

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-6.127 - 0 - 0.322) / 29.917
=-0.215563

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sol-Gel Technologies has a M-score of -3.56 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.56 mean?
Sol-Gel Technologies (SLGL) has a Beneish M-Score of -3.56 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Sol-Gel Technologies and its competitors. According to the industry distribution chart, Sol-Gel Technologies ranks #132 out of 831 companies in the Biotechnology industry, placing it in the top 15.9%.
Is Sol-Gel Technologies' Beneish M-Score too high?
Sol-Gel Technologies' current Beneish M-Score is -3.56. Based on the distribution chart, Sol-Gel Technologies ranks #132 out of 831 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sol-Gel Technologies has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' Beneish M-Score compare to ALEC and LENZ?
According to the Biotechnology industry distribution chart, Sol-Gel Technologies ranks #132 out of 831 companies for Beneish M-Score. This places Sol-Gel Technologies in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Sol-Gel Technologies and its competitors. Sol-Gel Technologies's current Beneish M-Score is -3.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.37, compared to a current price of $73.50 — trading 12.4% above its estimated fair value. The current Beneish M-Score is -3.56. Sol-Gel Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current Beneish M-Score is -3.56 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $73.50 is trading 12.4% above its estimated GF Value™ of $65.37. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

  • Beneish M-Score: -3.56
  • GF Value™: $65.37 vs. price of $73.50 (12.4% above fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SLGL

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.50
Price
$65.37
GF Value